| Mr Dustin Burnham, | |
|
1350 Hickory St, Melbourne, FL 32901-3224 | |
| (321) 434-7144 | |
| Not Available |
| Full Name | Mr Dustin Burnham |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology Assistant |
| Experience | 8 Years |
| Location | 1350 Hickory St, Melbourne, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346790011 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | AA586 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cleveland Clinic Indian River Hospital | Vero beach, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Indian River Health Services Inc | 9234130329 | 288 |
News Archive
The debate about two studies showing that, with few genetic mutations, H5N1 bird flu strains could become more easily transmissible among ferrets, a laboratory model for humans, "has become a debate about the role of science in society.
InfraReDx, Inc., an innovative medical device company focused on developing novel diagnostic imaging technologies to accurately identify and characterize diseased intracoronary tissues, today announced that the Company's LipiScan™ Coronary Imaging System will be highlighted in multiple sessions during the 59th Annual Scientific Session of the American College of Cardiology.
Interleukin Genetics, Inc. announced today it has entered into an agreement with Amway Global. With this agreement, Amway Global Independent Business Owners will be able to sell Interleukin Genetics' Inherent Health(TM) brand of genetic tests, including the new Weight Management Genetic Test.
GlaxoSmithKline (GSK) and ChemoCentryx, Inc. today announced that GSK has exercised its option to obtain an exclusive license for further development and worldwide commercialization of Traficet-EN(TM) (CCX282-B), a specific CCR9 antagonist with the potential to offer a new approach for the treatment of inflammatory bowel diseases, including Crohn's disease.
› Verified 1 days ago
| Entity Name | Florida Clinical Practice Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063463768 PECOS PAC ID: 0345146254 Enrollment ID: O20031211000099 |
News Archive
The debate about two studies showing that, with few genetic mutations, H5N1 bird flu strains could become more easily transmissible among ferrets, a laboratory model for humans, "has become a debate about the role of science in society.
InfraReDx, Inc., an innovative medical device company focused on developing novel diagnostic imaging technologies to accurately identify and characterize diseased intracoronary tissues, today announced that the Company's LipiScan™ Coronary Imaging System will be highlighted in multiple sessions during the 59th Annual Scientific Session of the American College of Cardiology.
Interleukin Genetics, Inc. announced today it has entered into an agreement with Amway Global. With this agreement, Amway Global Independent Business Owners will be able to sell Interleukin Genetics' Inherent Health(TM) brand of genetic tests, including the new Weight Management Genetic Test.
GlaxoSmithKline (GSK) and ChemoCentryx, Inc. today announced that GSK has exercised its option to obtain an exclusive license for further development and worldwide commercialization of Traficet-EN(TM) (CCX282-B), a specific CCR9 antagonist with the potential to offer a new approach for the treatment of inflammatory bowel diseases, including Crohn's disease.
› Verified 1 days ago
| Entity Name | Indian River Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710933031 PECOS PAC ID: 9234130329 Enrollment ID: O20070116000060 |
News Archive
The debate about two studies showing that, with few genetic mutations, H5N1 bird flu strains could become more easily transmissible among ferrets, a laboratory model for humans, "has become a debate about the role of science in society.
InfraReDx, Inc., an innovative medical device company focused on developing novel diagnostic imaging technologies to accurately identify and characterize diseased intracoronary tissues, today announced that the Company's LipiScan™ Coronary Imaging System will be highlighted in multiple sessions during the 59th Annual Scientific Session of the American College of Cardiology.
Interleukin Genetics, Inc. announced today it has entered into an agreement with Amway Global. With this agreement, Amway Global Independent Business Owners will be able to sell Interleukin Genetics' Inherent Health(TM) brand of genetic tests, including the new Weight Management Genetic Test.
GlaxoSmithKline (GSK) and ChemoCentryx, Inc. today announced that GSK has exercised its option to obtain an exclusive license for further development and worldwide commercialization of Traficet-EN(TM) (CCX282-B), a specific CCR9 antagonist with the potential to offer a new approach for the treatment of inflammatory bowel diseases, including Crohn's disease.
› Verified 1 days ago
| Entity Name | Brevard Physician Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598008955 PECOS PAC ID: 1850535048 Enrollment ID: O20130909000619 |
News Archive
The debate about two studies showing that, with few genetic mutations, H5N1 bird flu strains could become more easily transmissible among ferrets, a laboratory model for humans, "has become a debate about the role of science in society.
InfraReDx, Inc., an innovative medical device company focused on developing novel diagnostic imaging technologies to accurately identify and characterize diseased intracoronary tissues, today announced that the Company's LipiScan™ Coronary Imaging System will be highlighted in multiple sessions during the 59th Annual Scientific Session of the American College of Cardiology.
Interleukin Genetics, Inc. announced today it has entered into an agreement with Amway Global. With this agreement, Amway Global Independent Business Owners will be able to sell Interleukin Genetics' Inherent Health(TM) brand of genetic tests, including the new Weight Management Genetic Test.
GlaxoSmithKline (GSK) and ChemoCentryx, Inc. today announced that GSK has exercised its option to obtain an exclusive license for further development and worldwide commercialization of Traficet-EN(TM) (CCX282-B), a specific CCR9 antagonist with the potential to offer a new approach for the treatment of inflammatory bowel diseases, including Crohn's disease.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Dustin Burnham, 1775 W Hibiscus Blvd Ste 215, Melbourne, FL 32901-2627 Ph: (321) 837-3820 | Mr Dustin Burnham, 1350 Hickory St, Melbourne, FL 32901-3224 Ph: (321) 434-7144 |
News Archive
The debate about two studies showing that, with few genetic mutations, H5N1 bird flu strains could become more easily transmissible among ferrets, a laboratory model for humans, "has become a debate about the role of science in society.
InfraReDx, Inc., an innovative medical device company focused on developing novel diagnostic imaging technologies to accurately identify and characterize diseased intracoronary tissues, today announced that the Company's LipiScan™ Coronary Imaging System will be highlighted in multiple sessions during the 59th Annual Scientific Session of the American College of Cardiology.
Interleukin Genetics, Inc. announced today it has entered into an agreement with Amway Global. With this agreement, Amway Global Independent Business Owners will be able to sell Interleukin Genetics' Inherent Health(TM) brand of genetic tests, including the new Weight Management Genetic Test.
GlaxoSmithKline (GSK) and ChemoCentryx, Inc. today announced that GSK has exercised its option to obtain an exclusive license for further development and worldwide commercialization of Traficet-EN(TM) (CCX282-B), a specific CCR9 antagonist with the potential to offer a new approach for the treatment of inflammatory bowel diseases, including Crohn's disease.
› Verified 1 days ago
Jolene Keiko Goranovic, AA-C Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1304 Oak St, Melbourne, FL 32901 Phone: 321-723-4723 | |
Mr. Blake Anderson, BS, MS, CAA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 1775 W Hibiscus Blvd Ste 215, Melbourne, FL 32901 Phone: 321-837-3820 Fax: 321-837-3654 | |
Gregory Michael Hendershot, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1775 W Hibiscus Blvd Ste 215, Melbourne, FL 32901 Phone: 321-837-3820 Fax: 321-837-3654 | |
Andrew Sykes Curren, CAA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 1775 W Hibiscus Blvd Ste 215, Melbourne, FL 32901 Phone: 321-837-3820 | |
Denesh Bhoodai, Anesthesiologist Assistant Medicare: Not Enrolled in Medicare Practice Location: 2627 W Eau Gallie Blvd Ste 101, Melbourne, FL 32935 Phone: 321-837-3820 Fax: 855-819-6516 | |
Anna Joy Miller, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1350 Hickory St, Melbourne, FL 32901 Phone: 808-633-3556 | |
Miss Natalie Brecese, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1775 W Hibiscus Blvd, Suite 215, Melbourne, FL 32901 Phone: 321-837-3820 |